Literature DB >> 1349605

Mass spectrometry of mRNA cap 4 from trypanosomatids reveals two novel nucleosides.

J D Bangs1, P F Crain, T Hashizume, J A McCloskey, J C Boothroyd.   

Abstract

Synthesis of mRNA in kinetoplastid protozoa involves the process of trans-splicing, in which an identical 39-41-nucleotide (depending on the species) mini-exon is placed at the 5' end of mature mRNAs. The mini-exon sequence is highly conserved among all members of the Kinetoplastida, nucleotides 1-6 being identical in the four genera so far examined. Prior to trans-splicing, the mini-exon donor RNA is capped by the addition of a (5'-5') triphosphate-linked 7-methylguanosine, followed by modification of the first four transcribed nucleotides. Partial structures have been previously deduced for this cap 4 moiety from Trypanosoma brucei and Leptomonas collosoma. We have purified enough cap 4 from T. brucei and Crithidia fasciculata to allow definitive structural analysis by combined liquid chromatography/mass spectrometry and gas chromatography/mass spectrometry. The results, together with the known mini-exon sequence, show that cap 4 in both species has the structure m7G(5')ppp(5')m6(2)AmpAmpCmpm3Ump. The presence of N6,N6,2'-O-trimethyladenosine and 3,2'-O-dimethyluridine, nucleosides previously unknown in nature, were confirmed by rigorous comparison with synthetic standards. The conservation of cap 4 between these divergent genera suggests that this structure may be common to most if not all Kinetoplastida.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349605

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  85 in total

1.  Trypanosome spliced leader RNA genes contain the first identified RNA polymerase II gene promoter in these organisms.

Authors:  G Gilinger; V Bellofatto
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

Review 2.  Unconventional rules of small nuclear RNA transcription and cap modification in trypanosomatids.

Authors:  Christian Tschudi; Elisabetta Ullut
Journal:  Gene Expr       Date:  2002

Review 3.  trans and cis splicing in trypanosomatids: mechanism, factors, and regulation.

Authors:  Xue-hai Liang; Asaf Haritan; Shai Uliel; Shulamit Michaeli
Journal:  Eukaryot Cell       Date:  2003-10

4.  Chemical synthesis and binding activity of the trypanosomatid cap-4 structure.

Authors:  Magdalena Lewdorowicz; Yael Yoffe; Joanna Zuberek; Jacek Jemielity; Janusz Stepinski; Ryszard Kierzek; Ryszard Stolarski; Michal Shapira; Edward Darzynkiewicz
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

5.  SmD1 is required for spliced leader RNA biogenesis.

Authors:  Gusti M Zeiner; Silvie Foldynová; Nancy R Sturm; Julius Lukes; David A Campbell
Journal:  Eukaryot Cell       Date:  2004-02

Review 6.  Enzymology of RNA cap synthesis.

Authors:  Agnidipta Ghosh; Christopher D Lima
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-25       Impact factor: 9.957

7.  Identification of mRNA decapping activities and an ARE-regulated 3' to 5' exonuclease activity in trypanosome extracts.

Authors:  Joseph Milone; Jeffrey Wilusz; Vivian Bellofatto
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

8.  Novel and essential subunits in the 300-kilodalton nuclear cap binding complex of Trypanosoma brucei.

Authors:  Hongjie Li; Christian Tschudi
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Rapid block of pre-mRNA splicing by chemical inhibition of analog-sensitive CRK9 in Trypanosoma brucei.

Authors:  Ujwala Gosavi; Ankita Srivastava; Nitika Badjatia; Arthur Günzl
Journal:  Mol Microbiol       Date:  2020-03-04       Impact factor: 3.501

10.  Cap-binding activity of an eIF4E homolog from Leishmania.

Authors:  Yael Yoffe; Joanna Zuberek; Magdalena Lewdorowicz; Ziv Zeira; Chen Keasar; Irit Orr-Dahan; Marzena Jankowska-Anyszka; Janusz Stepinski; Edward Darzynkiewicz; Michal Shapira
Journal:  RNA       Date:  2004-09-23       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.